How Revolutionary PCR Technology is Advancing Vital Cancer Research
Watch industry leading scientists discuss the very latest developments in cancer research, made possible with digital PCR technology
Watch industry leading scientists discuss the very latest developments in cancer research, made possible with digital PCR technology
TwistDx’s proprietary technology, Recombinase Polymerase Amplification (RPA), is transforming the ability to amplify and detect nucleic acids, in laboratory and resource-limited field settings
Learn about new research technologies available and the Life Sciences Scientists’ Choice Awards winners
Find out how droplet digital PCR is being used at the very forefront of vital healthcare research
Discover how this leading London Biomedical Research Center is using state-of-the-art genomics to improve healthcare
Agreement centered on next-generation sequencing oncology research and companion diagnostic development programs
Improving RNA single cell genomics and sequencing library preparation protocols
New biomarker test designed to aid diagnosis of patients suspected of having Polycythemia Vera form of blood cancer
Dr Jim Huggett, LGC & University of Surrey, discusses the results of a study into international inter-laboratory digital PCR
First comparison of a biomarker analysis by RT-qPCR (MammaTyper®) versus visual or computer-assisted immunohistochemistry (IHC) in subtyping mammary carcinomas